Research-Grade Sterile Lab•
Real Third-Party Report•
Purity & Quality Guaranteed•
Research-Grade Sterile Lab•
Real Third-Party Report•
Purity & Quality Guaranteed•
  • info@hytanpeptides.com
Facebook-f Instagram X-twitter
Pure Peptide at Hytan Bio |Pure Lab Peptides |Wholesale Partners Lab USA

Glow

GLOW is a synergistic three-peptide research blend combining GHK-Cu, BPC-157, and TB-500. Optimized for dermatological and soft tissue regenerative research, it targets collagen synthesis, skin rejuvenation, wound healing, inflammation modulation, and extracellular matrix remodeling.
GLOW is an advanced, skin-focused tri-peptide lyophilized research formulation (70mg total per vial, standard ratio: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) optimized for dermatological and soft tissue regenerative research. Each component delivers complementary, skin-focused biological activity:
GLOW is an advanced, skin-focused tri-peptide lyophilized research formulation (70mg total per vial, standard ratio: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) optimized for dermatological and soft tissue regenerative research. Each component delivers complementary, skin-focused biological activity:
  1. GHK-Cu (Copper Peptide): Stimulates type I/III collagen and elastin synthesis, enhances glycosaminoglycan production, supports keratinocyte migration, and modulates gene expression related to extracellular matrix remodeling to improve skin firmness, texture, and reduce visible signs of aging
  2. BPC-157: Promotes dermal angiogenesis, accelerates wound and scar healing, reduces skin inflammation, and supports connective tissue repair
  3. TB-500: Enhances fibroblast migration, supports rapid tissue regeneration, and improves microvascularization to deliver nutrients to regenerating skin tissue
Designed for preclinical and in vitro research, GLOW enables investigation of combined skin regenerative pathways in models of skin anti-aging, scar reduction, wound healing, dermatological inflammation, and soft tissue repair. All components are manufactured to ≥98% purity, sterile-filtered, and lyophilized for long-term stability.

For laboratory research use only; not intended for human or veterinary administration.
Request Quote / COA

By submitting this form, you confirm the product is intended for laboratory research use only.

Related Research Peptides

PT-141 (Bremelanotide) is a cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), acting as a central melanocortin (MC3/MC4) receptor agonist. FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women, it acts directly on brain neural circuits to stimulate sexual desire and arousal, operating via a distinct central mechanism rather than peripheral vasodilation.

PT141

Wholesale
Read More
AOD9604 is a 16-amino acid C-terminal fragment of human growth hormone (hGH residues 176–191). It selectively stimulates fat breakdown (lipolysis) and inhibits new fat formation (lipogenesis) via β3-adrenergic receptor activation, without elevating IGF-1 or causing the systemic growth-related side effects of full-length hGH, making it a targeted peptide for fat metabolism research.

AOD9604

Wholesale
Read More
Tesamorelin is a stabilized 44-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH). It is the only FDA-approved GHRH analog (marketed as Egrifta) for reducing visceral adipose tissue in HIV-associated lipodystrophy, and stimulates physiological pulsatile endogenous growth hormone (GH) and IGF-1 secretion to support selective visceral fat loss and metabolic regulation in research.

Tesamorelin

Wholesale
Read More
KLOW is a synergistic four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV. Formulated for regenerative research applications, it simultaneously targets inflammation modulation, multi-tissue repair, angiogenesis, cellular regeneration, and skin rejuvenation.

Klow

Wholesale
Read More